BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 16954072)

  • 21. Stereotactic biopsy of brain stem masses: Decision analysis and literature review.
    Samadani U; Stein S; Moonis G; Sonnad SS; Bonura P; Judy KD
    Surg Neurol; 2006 Nov; 66(5):484-90; discussion 491. PubMed ID: 17084194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reliability of stereotactic biopsy. A model to test the value of diagnoses obtained from small fragments of nervous system tumors.
    de Divitiis E; Spaziante R; Cappabianca P; Caputi F; Pettinato G; Del Basso De Caro M
    Appl Neurophysiol; 1983; 46(5-6):295-303. PubMed ID: 6375567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Computerized stereotactic brain biopsies: an experience of 15 patients at Ayub Teaching Hospital.
    Bhatti SN; Ayub S; Aurangzeb A; Haq AU; Jamil M; Ali J; Ahmad A; Kashif M
    J Ayub Med Coll Abbottabad; 2005; 17(3):26-8. PubMed ID: 16320791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subcutaneous tumoral seeding from a glioblastoma following stereotactic biopsy: case report and review of the literature.
    Bouillot-Eimer S; Loiseau H; Vital A
    Clin Neuropathol; 2005; 24(6):247-51. PubMed ID: 16320817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
    Jung CS; Foerch C; Schänzer A; Heck A; Plate KH; Seifert V; Steinmetz H; Raabe A; Sitzer M
    Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.
    Hermann EJ; Hattingen E; Krauss JK; Marquardt G; Pilatus U; Franz K; Setzer M; Gasser T; Tews DS; Zanella FE; Seifert V; Lanfermann H
    Stereotact Funct Neurosurg; 2008; 86(5):300-7. PubMed ID: 18791331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy.
    Setzer M; Herminghaus S; Marquardt G; Tews DS; Pilatus U; Seifert V; Zanella F; Lanfermann H
    Acta Neurochir (Wien); 2007; 149(4):379-86. PubMed ID: 17380247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen.
    Chandrasoma PT; Smith MM; Apuzzo ML
    Neurosurgery; 1989 Feb; 24(2):160-5. PubMed ID: 2537475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "Two is not enough" - Impact of the number of tissue samples obtained from stereotactic brain biopsies in suspected glioblastoma.
    Quick-Weller J; Tichy J; Harter PN; Tritt S; Baumgarten P; Bähr O; Dinc N; Behmanesh B; Weise L; Seifert V; Marquardt G
    J Clin Neurosci; 2018 Jan; 47():311-314. PubMed ID: 29078974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stereotactic biopsy of 100 intracerebral lesions at Sir Charles Gairdner Hospital.
    Robbins PD; Yu LL; Lee M; Stokes BA; Thomas GW; Watson P; Wong G
    Pathology; 1994 Oct; 26(4):410-3. PubMed ID: 7892040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphologic evaluation of stereotactic brain tumour biopsies.
    Kleihues P; Volk B; Anagnostopoulos J; Kiessling M
    Acta Neurochir Suppl (Wien); 1984; 33():171-81. PubMed ID: 6375290
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metastasis along the stereotactic biopsy trajectory in glioblastoma multiforme.
    Pierallini A; Caramia F; Piattella MC; Pantano P; Santoro A; Di Stefano D; Bozzao L
    Acta Neurochir (Wien); 1999; 141(9):1011-2. PubMed ID: 10526085
    [No Abstract]   [Full Text] [Related]  

  • 33. [Delayed brain haematoma following stereotactic biopsy].
    Gelabert-González M
    Neurocirugia (Astur); 2007 Feb; 18(1):36-9. PubMed ID: 17393044
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smear biopsy for on-the-spot diagnosis in stereotactic surgery of CNS tumors. Experience of 101 cases.
    Ferracini R; Poletti V; Manetto V; Frank-Ricci R; Del Borrello E
    Ital J Neurol Sci; 1987 Aug; 8(4):347-9. PubMed ID: 3316117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk reduction with stereotactic brain biopsies: keys to success.
    Dickerman RD; Reynolds AS; Stevens Q
    Surg Neurol; 2007 Feb; 67(2):216; author reply 216. PubMed ID: 17254897
    [No Abstract]   [Full Text] [Related]  

  • 36. Does intensity-modulated stereotactic radiotherapy achieve superior target conformity than conventional stereotactic radiotherapy in different intracranial tumours?
    Sharma SD; Jalali R; Phurailatpam RD; Gupta T
    Clin Oncol (R Coll Radiol); 2009 Jun; 21(5):408-16. PubMed ID: 19268555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropathological diagnosis with stereotactic biopsies. Possibilities, difficulties and requirements.
    Brucher JM
    Acta Neurochir (Wien); 1993; 124(1):37-9. PubMed ID: 8279291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Anatomopathologic diagnostic methods of primary cerebral lymphoma].
    Bataille B
    Neurochirurgie; 1997; 43(6):369. PubMed ID: 9706614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validity of stereotactic biopsy as a diagnostic tool.
    Colombo F; Casentini L; Zanusso M; Danieli D; Benedetti A
    Acta Neurochir Suppl (Wien); 1988; 42():152-6. PubMed ID: 3055823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in patients undergoing single-trajectory endoscopic third ventriculostomy and endoscopic biopsy for midline tumors presenting with obstructive hydrocephalus.
    O'Brien DF; Hayhurst C; Pizer B; Mallucci CL
    J Neurosurg; 2006 Sep; 105(3 Suppl):219-26. PubMed ID: 16970236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.